Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$908.4M
+19.9% from 2023
Prescriptions
39K
$23,071.34 per claim
Patients
4,318
1,533 prescribers
Total spending
-
All plans
Medicare prescription drug plans paid $908.4M for Uptravi in 2024, for 39,375 prescriptions and refills to 4,318 patients (up 19.9% from 2023). The average cost per claim was $23,071.34.
California had the highest Medicare cost for Uptravi in 2024: $92.1M for 4,151 claims, followed by Texas ($76.8M).
Jean M Elwing, pulmonary disease in Cincinnati, OH, had the highest Medicare cost for Uptravi in 2024: 565 claims costing $13.6M.
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jean M Elwing Cincinnati, OH | Pulmonary Disease | 565 | 65 | $13.6M |
| John W McConnell Louisville, KY | Pulmonary Disease | 476 | 53 | $10.7M |
| Hunter C Champion Sr. |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,240 | 27,705 | 3,281 | $582.8M |
| 2023 | 1,386 | 33,011 | 3,725 | $757.9M |
| 2024 | 1,533 | 39,375 | 4,318 | $908.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Cardiology |
| 474 |
| 55 |
| $10.0M |
| John Kingrey Oklahoma City, OK | Pulmonary Disease | 351 | 40 | $7.7M |
| Therese J Sargent Phoenix, AZ | Nurse Practitioner | 335 | 44 | $7.4M |
| Terry A Fortin Durham, NC | Cardiology | 310 | 25 | $6.8M |
| Sandeep Sahay Houston, TX | Pulmonary Disease | 273 | 26 | $6.2M |
| Ronald Zolty Omaha, NE | Advanced Heart Failure and Transplant Cardiology | 230 | 29 | $5.5M |
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 226 | 23 | $5.3M |
| Kimberly C Thompson Rochester, MN | Nurse Practitioner | 221 | 26 | $5.2M |
| Peter J Leary Seattle, WA | Pulmonary Disease | 212 | 26 | $5.0M |
| Frank Cefali New York, NY | Nurse Practitioner | 222 | 36 | $5.0M |
| Sivagini Ganesh Los Angeles, CA | Pulmonary Disease | 252 | 23 | $4.9M |
| Mrinalini Krishnan Philadelphia, PA | Advanced Heart Failure and Transplant Cardiology | 214 | 24 | $4.9M |
| Lillian M Hansen Tucson, AZ | Nurse Practitioner | 216 | 23 | $4.9M |
| Robert L Scott Phoenix, AZ | Advanced Heart Failure and Transplant Cardiology | 217 | 27 | $4.6M |
| Choon Hwa Goh San Francisco, CA | Cardiology | 212 | 19 | $4.4M |
| Emily Fedewa San Francisco, CA | Nurse Practitioner | 199 | 27 | $4.3M |
| Hooman D Poor New York, NY | Pulmonary Disease | 179 | 25 | $4.2M |
| Kenneth Presberg Milwaukee, WI | Pulmonary Disease | 183 | 23 | $4.1M |
| John D Dallas Austin, TX | Pulmonary Disease | 185 | 17 | $4.0M |
| Christina M Eagan Gainesville, FL | Nurse Practitioner | 172 | 18 | $4.0M |
| Zeenat Safdar Houston, TX | Pulmonary Disease | 183 | 19 | $3.9M |
| Lori G Reed Marietta, GA | Nurse Practitioner | 159 | 20 | $3.8M |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 151 | 17 | $3.7M |